This inventor holds 1 USPTO granted patent. Top assignee: The Nemours Foundation. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Seung Joon Lee: Innovator in Cancer Treatment
Introduction
Seung Joon Lee is a prominent inventor based in Bear, Delaware, known for his significant contributions to cancer treatment methodologies. His innovative approach focuses on utilizing phosphorylated Cdc27 in cancer cells to enhance treatment efficacy.
Latest Patents
Seung Joon Lee holds a patent titled "Method for treating cancer with agents that bind phosphorylated CDC27." This patent outlines a method that identifies patients likely to benefit from chemotherapeutic agents that target phosphorylated Cdc27. The patent emphasizes the use of compounds like curcumin to determine patient responses to treatment.
Career Highlights
Seung Joon Lee is affiliated with The Nemours Foundation, where he continues to advance research in cancer therapies. His work is pivotal in developing targeted treatments that improve patient outcomes.
Collaborations
He collaborates with Sigrid Anne-Barbara Langhans, contributing to the research and development of innovative cancer treatment strategies.
Conclusion
Seung Joon Lee's work exemplifies the intersection of innovation and healthcare, particularly in the fight against cancer. His contributions are vital for the future of targeted cancer therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile